bioMérieux's Latest 32,000 sq. ft. Global Food Safety and Quality Site is Home to the xPRO TM Program that Rapidly Innovates Cutting-Edge Molecular Assays in Partnership with Industry Leaders PHILADELPHIA , Sept.
18, 2024 /PRNewswire/ -- bioMérieux, a world leader in in vitro diagnostics, celebrates the opening of the company's Molecular and Genomic Innovation Center . The new 32,000 sq. ft.
facility is home to the xPROTM Program, which has rapidly changed the landscape of food safety diagnostic capabilities by partnering directly with industry leaders to address unmet needs to streamline operational efficiencies and further public health. bioMérieux's global leadership team was on-site for the ribbon cutting event, as Philadelphia continues to fortify its reputation as a hotbed of innovation in Life Sciences across North America . "The opening of the Molecular and Genomic Innovation Center at the Navy Yard is an important milestone in bioMérieux's storied legacy, as we continue to provide game changing diagnostic solutions that solve the food safety industry's most persistent and urgent challenges," said Miguel Villa, Sr.
Vice President, Industrial Applications, Americas, and xPROTM sponsor, "This facility - in conjunction with our unique Augmented Diagnostics approach to food safety - allows us to continue redefining the role and capabilities of diagnostic testing to further ensure public health and fortify brand reputations." Since 2019, the xPRO TM Program has con.